Page 3 - Buzz Show News Today

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Auris Medical Provides Update on Bentrio Program in Allergy” Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders, and its affiliate Altamira Medica Ltd. today announced additional details on the outcomes from the clinical investigation of its BentrioTM nasal ...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “MicroVision Announces Completion of its Long-Range Lidar Sensor A-Sample Hardware and Development Platform” MicroVision, Inc. (NASDAQ: MVIS) gained over 10% in premarket trading after announcing the Completion of its Long-Range Lidar Sensor A-Sample Hardware and Development Platform. The Company has completed development of its platform for demonstration of key performance features of its long-range lidar se...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ADMA Biologics Receives FDA Approval for Increased Intravenous Immune Globulin Production Scale” ADMA Biologics (NASDAQ: ADMA), Inc. shot up over 23% in premarket trading after the company was granted approval for an Increased Intravenous Immune Globulin Production Scale by the FDA. The 4,400-liter IVIG plasma pool scale for BIVIGAM® will allow ADMA to expand its manufacturing plant’s total processing cap...

Sponsored Content Release FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding,...

FinancialBuzz.com’s latest Affimed N.V. (NASDAQ: AFMD) surged over 30% in premarket trading after the company announced positive initial clinical data from an investigator-sponsored study at The University of Texas MD Anderson Cancer Center. The study evaluated cord blood-derived natural killer cells pre-complexed with Affimed’s innate cell engager and all four patients experienced significant disease reduction, with two complete responses and two partial responses as assessed by the inve...

Sponsored Content Release FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemina...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Zhongchao Inc. Shares Rise After Renewing its Contract with China Association of Health Promotion and Education and GlaxoSmithKline” Zhongchao Inc. (NASDAQ: ZCMD) shot up just over 87% in premarket trading after the company renewed its partnership with the China Association for Health Promotion and Education and GlaxoSmithKline Investment Limited. The partnership seeks to continue the medical education prog...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “NLS Pharmaceutics Ltd. Surges Amid License Agreement with Novartis Pharma AGs”FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “NLS Pharmaceutics Ltd. Surges Amid License Agreement with Novartis Pharma AGs” NLS Pharmaceutics Ltd. (NASDAQ: NLSP) shot up over 109% in premarket trading after the Company had entered into a License Agreement with Novartis Pharma AG. The agreemen...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Second Sight Medical Receives FDA Approval for the Argus 2s Retinal Prosthesis System” Second Sight Medical (NASDAQ: EYES) Products surged just under 60% in premarket trading after the company announced the U.S. Food and Drug Administration has approved the Argus 2s Retinal Prosthesis System. The Company expects that the redesigned set of external hardware initially for use in combination with previously im...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ Revolution Acceleration RIses Amid SPAC deal for robotics firm Berkshire Grey” Revolution Acceleration Acquisition Corp (NYSE: RAAC) gained over 17% in premarket trading after Berkshire Grey entered into a definitive agreement with the Company. The agreement will now create a leading publicly listed robotics and automation solutions company with a post-transaction equity value of up to $2.7 billion. First, ...